Objectives.\ud \ud To determine whether genetic polymorphisms in or near the transforming growth factor 1(TGFB1) locus were associated with susceptibility to or severity of ankylosing spondylitis (AS). \ud \ud Methods.\ud \ud Five intragenic single-nucleotide polymorphisms (SNP) and three microsatellite markers flanking the TGFB1 locus were genotyped. Seven hundred and sixty-two individuals from 184 multiplex families were genotyped for the microsatellite\ud markers and two of the promoter SNPs. One thousand and two individuals from 212 English and 170 Finnish families with AS were genotyped for all five intragenic SNPs. A Structured questionnaire was used to assess the age of symptom onset, disease duration and disease severity scores, inc...
Ankylosing spondylitis (AS) is a chronic inflammatory disease in which genetic factors play a centra...
<div><p>Ankylosing spondylitis (AS) is a highly familial rheumatic disorder and is considered as a c...
Florence WL Tsui,1,2 Hing Wo Tsui,1 Ali Akram,1,3 Nigil Haroon,1–3 Robert D Inman1–3 1Ge...
Objectives. To determine whether genetic polymorphisms in or near the transforming growth factor bet...
Objectives. To determine whether genetic polymorphisms in or near the transforming growth factor β1 ...
Objectives: To determine whether genetic polymorphisms in or near the transforming growth factor 1(T...
OBJECTIVES: To determine whether genetic polymorphisms in or near the transforming growth factor bet...
Objectives. To investigate the role of polymorphisms of the vascular endothelial growth factor (VEGF...
Objectives. To study serum levels of transforming growth factor beta-1 (TGFb1) and the expression of...
Objective. To identify genomic regions linked with determinants of age at symptom onset, disease act...
Functional severity in ankylosing spondylitis (AS) patients is variable and difficult to predict ear...
OBJECTIVE: To identify genomic regions linked with determinants of age at symptom onset, disease act...
While twin studies have previously demonstrated high heritability of susceptibility to ankylosing sp...
Ankylosing spondylitis (AS) is a systemic, chronic and inflammatory disease in which the spine and p...
While twin studies have previously demonstrated high heritability of susceptibility to ankylosing sp...
Ankylosing spondylitis (AS) is a chronic inflammatory disease in which genetic factors play a centra...
<div><p>Ankylosing spondylitis (AS) is a highly familial rheumatic disorder and is considered as a c...
Florence WL Tsui,1,2 Hing Wo Tsui,1 Ali Akram,1,3 Nigil Haroon,1–3 Robert D Inman1–3 1Ge...
Objectives. To determine whether genetic polymorphisms in or near the transforming growth factor bet...
Objectives. To determine whether genetic polymorphisms in or near the transforming growth factor β1 ...
Objectives: To determine whether genetic polymorphisms in or near the transforming growth factor 1(T...
OBJECTIVES: To determine whether genetic polymorphisms in or near the transforming growth factor bet...
Objectives. To investigate the role of polymorphisms of the vascular endothelial growth factor (VEGF...
Objectives. To study serum levels of transforming growth factor beta-1 (TGFb1) and the expression of...
Objective. To identify genomic regions linked with determinants of age at symptom onset, disease act...
Functional severity in ankylosing spondylitis (AS) patients is variable and difficult to predict ear...
OBJECTIVE: To identify genomic regions linked with determinants of age at symptom onset, disease act...
While twin studies have previously demonstrated high heritability of susceptibility to ankylosing sp...
Ankylosing spondylitis (AS) is a systemic, chronic and inflammatory disease in which the spine and p...
While twin studies have previously demonstrated high heritability of susceptibility to ankylosing sp...
Ankylosing spondylitis (AS) is a chronic inflammatory disease in which genetic factors play a centra...
<div><p>Ankylosing spondylitis (AS) is a highly familial rheumatic disorder and is considered as a c...
Florence WL Tsui,1,2 Hing Wo Tsui,1 Ali Akram,1,3 Nigil Haroon,1–3 Robert D Inman1–3 1Ge...